inVentiv Adds Execs

inVentiv Health Clinical has appointed of a president of Phase II-IV Development, chief medical Officer, and chief Financial Officer to strengthen its leadership team.

Dawn Anderson joins inVentiv Clinical as president, Phase II-IV Development, Martin Birkhofer, M.D.  assumes the newly created position of chief medical officer, and Richard Shimota becomes chief financial officer. Ms. Anderson, Dr. Birkhofer, and Mr. Shimota will serve on the inVentiv’s executive leadership team. The additional of the senior talent was fueled by significant new wins in all areas of the clinical business, including Early Stage, Phase II-IV and Strategic Resourcing, according to a company statement.

Ms. Anderson has more than 20 years’ experience in the clinical field across various management positions. Her experience includes leadership roles across clinical development and operations, portfolio and program management, and process optimization at pharmaceutical and biotech companies, start-ups and CROs. She most recently served as Cognizant’s global head of Clinical Operations and Transformation. Prior to that, she held a number of senior roles at Quintiles.

In the newly created role of chief medical officer, Dr. Birkhofer, a medical oncologist by training, will oversee strategic investment in areas that expand upon the company’s capabilities. He will advise the business on industry trends and issues and build relationships with chief medical officers and senior executives within client organizations. A 19-year veteran of Bristol-Myers Squibb, Dr. Birkhofer most recently served as vice president, Business Development, leading global search, evaluation, and diligence for worldwide business development. He previously managed Global Medical Affairs for oncology, leading the development team responsible for the U.S. registration, launch and life cycle management of Erbitux in colorectal cancer, as well as head and neck tumors.

As chief financial officer, Mr. Shimota brings nearly 30 years of professional experience in operational finance roles of increasing responsibility, most recently serving in that role at Shaw Power, a division of The Shaw Group, Inc.

“With the addition of three such seasoned executives, we are strengthening our leadership team with a Medical Officer steeped in industry knowledge, a skilled CFO with a background in project-based businesses, and a strong leader for Phase II-IV  who has deep clinical development experience,” said Raymond Hill, president of inVentiv Health Clinical. “I am confident that they will help guide our organization along the successful path we’ve followed since the start of the year through to our next stage of growth.”